FEATURED NEWS

• Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies

  May 12, 2022

  The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the signing of SB 823 by Maryland Governor Larry Hogan.

• HDA’s PCSC Honors Four Outstanding Security Leaders at Annual Seminar

  April 20, 2022

  The Healthcare Distribution Alliance (HDA) Pharmaceutical Cargo Security Coalition (PCSC) today recognized four security leaders at the annual PCSC Educational Seminar in Whippany, N.J. The PCSC Award is presented to supply chain security professionals who have exhibited remarkable standards of honesty and integrity while working tirelessly to protect and serve their communities.

• HDA Applauds Senate Passage of Maryland Legislation Designed To Clarify Role of Critical Pharmacy Partners

  April 4, 2022

  The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the passage of SB 823 by the Maryland Senate.

• Rx Supply Chain Progressing on EPCIS Adoption for DSCSA, Yet Challenges Still Remain

  March 17, 2022

  Updated survey data released today by the HDA Research Foundation indicate that healthcare supply chain partners remain in the formative stages of establishing the interoperable transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) by November 27, 2023. However, some progress has been made since a previous survey conducted last spring.

• HDA Statement on the PREVENT Pandemics Act

  March 15, 2022

  The Healthcare Distribution Alliance (HDA) applauds the leadership of Senate Health, Education, Labor, and Pensions (HELP) Committee’s Chairwoman Murray (D-Wash.) and Ranking Member Burr (R-N.C.) for introducing the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act), a bipartisan public health effort to build stronger national medical preparedness and response systems in the wake of the COVID-19 pandemic. The overwhelming support for the legislation during the HELP Committee markup today, March 15, showed that Congress is making significant, positive steps towards reforms necessary to ensure the availability of lifesaving pharmaceutical treatments and medical supplies in response to future crises.